You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Elderly patients not eligible for intensive chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Tianjin (Different induction chemo regimens)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Different induction chemotherapy regimens
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Sep 27, 2023

Acute Myeloid Leukemia Trial in Germany (Venetoclax plus Azacitidine, standard of care chemo plus gemtuzumab ozogamicin)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Venetoclax plus Azacitidine
  • standard of care chemotherapy plus gemtuzumab ozogamicin
  • Essen, NRW, Germany
  • +17 more
Jun 6, 2023

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

Active, not recruiting
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +9 more
  • Sewell, New Jersey
  • +4 more
Dec 13, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Decitabine and

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 1, 2022

Acute Myeloid Leukemia, MDS, Transplant-Related Hematologic Malignancy Trial in Milano (Fludarabine, ARA-C, Treosulfan)

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Milano, Lombardia, Italy
    Ospedale San Raffaele
Jul 18, 2022

Acute Myeloid Leukemia Trial (Sulfasalazine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Oct 11, 2022

Lymphoma, Extranodal NK-T-Cell Trial in Shanghai (Pembrolizumab, Involved Field Radiation Therapy)

Recruiting
  • Lymphoma, Extranodal NK-T-Cell
  • Shanghai, China
    Shanghai Rui-Jin Hospital
Mar 29, 2022

Leukemia, Myeloid Trial in Worldwide (CC-90011, Venetoclax, Azacitidine)

Completed
  • Leukemia, Myeloid
  • Duarte, California
  • +34 more
Apr 26, 2022

Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute

Recruiting
  • Acute Myeloid Leukemia, Adult
  • +2 more
  • Trieste, Italy
    SC Ematologia Ospedale Maggiore
Sep 14, 2020

Acute Myeloid Leukemia Trial in Chicago (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Chicago, Illinois
    Northwestern University
Feb 16, 2023

Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Cusatuzumab)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Darlinghurst, Australia
  • +55 more
Dec 28, 2022

Acute Myeloid Leukemia Trial in New York (CPX-351, Gemtuzumab Ozogamicin)

Recruiting
  • Acute Myeloid Leukemia
  • New York, New York
    Weill Cornell Medical College
Dec 21, 2021

Acute Myeloid Leukaemia Trial in Australia, United States (AZD2811, Azacitidine, Venetoclax)

Terminated
  • Acute Myeloid Leukaemia
  • Denver, Colorado
  • +10 more
Mar 24, 2022

Acute Myeloid Leukemia (AML) Trial in Worldwide (standard combination chemo, decitabine)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Edegem, Antwerpen, Belgium
  • +52 more
Sep 13, 2022

Leukemia, Myeloid, Acute Trial in Portugal, Spain (Pevonedistat, Azacitidine)

Active, not recruiting
  • Leukemia, Myeloid, Acute
  • Coimbra, Portugal
  • +63 more
Sep 9, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in France (Durvalumab with Carboplatin/Paclitaxel)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Durvalumab with Carboplatin/Paclitaxel
  • Amiens, France
  • +19 more
Mar 14, 2022

Leukemia, Myeloid, Acute Trial (The combination of HHT, venetoclax, AZA, G-CSF)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • The combination of HHT, venetoclax, AZA, G-CSF
  • (no location specified)
Mar 28, 2021

Acute Myeloid Leukemia Trial in Worldwide (S65487 and azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • S65487 and azacitidine
  • Villejuif, France
  • +7 more
Mar 25, 2022

Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

Recruiting
  • Acute Myeloid Leukemia
  • Venclexta 100 MG Oral Tablet
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023

Acute Myeloid Leukemia Trial in Praha (OmnImmune®)

Completed
  • Acute Myeloid Leukemia
  • OmnImmune®
  • Praha, Czechia
    UHKT (Ustav hematologie a krevni transfuze)
Mar 29, 2021

Acute Myeloid Leukemia Trial in France (GRASPA)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Nice, Alpes Maritimes, France
  • +20 more
Feb 18, 2022

Elderly Patients, Metastatic Lung Cancer Trial in Wuhan (Single drug chemo plus immunotherapy)

Not yet recruiting
  • Elderly Patients
  • Metastatic Lung Cancer
  • Single drug chemotherapy plus immunotherapy
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Sep 15, 2023

Acute Myeloid Leukemia, in Relapsed or Refractory, Acute Myeloid Leukemia, Elderly, Unfit, Acute Myeloid Leukemia With Positive

Unknown status
  • Acute Myeloid Leukemia, in Relapsed or Refractory
  • +2 more
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Sep 8, 2020

Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A, Fibroblast Growth Factor Basic Form Measurement, FLT3 Internal

Recruiting
  • Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A
  • +4 more
  • Chicago, Illinois
    Northwestern University
Apr 30, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Worldwide (Gilteritinib, Midostaurin)

Suspended
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome With Excess Blasts-2
  • Adelaide, Australia
  • +193 more
Jan 5, 2023